Skip to main content
Molecular Therapy. Methods & Clinical Development logoLink to Molecular Therapy. Methods & Clinical Development
. 2023 Feb 13;28:300. doi: 10.1016/j.omtm.2023.01.001

Enhancement of Adeno-Associated Virus-Mediated Gene Therapy Using Hydroxychloroquine in Murine and Human Tissues

Laurel C Chandler, Alun R Barnard, Sarah L Caddy, Maria I Patrício, Michelle E McClements, Howell Fu, Cristina Rada, Robert E MacLaren, Kanmin Xue
PMCID: PMC9950804  PMID: 36843676

Main text

(Molecular Therapy: Methods & Clinical Development 14, 77–89; September 2019)

In Figure 6C of the original published version of this article, the flow cytometry plot in the condition “AAV2.GFP + HCQpG-A” was inadvertantly duplicated from “AAV2.GFP + HCQ.” The duplicated plot has been replaced with the correct version. This minor editorial error did not affect the results or conclusions of the manuscript.

The authors apologize for the error.

graphic file with name gr6c.jpg

Figure 6. The Agonistic TLR9 Oligodeoxynucleotide CpG-A Decreases AAV Transduction in Wild-Type MEFs and Has a Significantly Reduced Effect in HCQ-Treated Cells (corrected)


Articles from Molecular Therapy. Methods & Clinical Development are provided here courtesy of American Society of Gene & Cell Therapy

RESOURCES